US$ 22.04
glp-1 impact on food industry The Effect: Opportunities for Innovation in the The Impact of GLP-1 on
Description
doi:10.1001/jamanetworkopen.2024.57349

The Lilly glucagon-like peptide-1 receptor (GLP-1R) agonist ( LSN3318839 ) is a positive allosteric modulator intended to treat type 2 diabetes
They also offer the

Study outcomes included the number needed to treat (NNT) to prevent one case of clinical events, healthcare costs, and cost per case of event prevented

Designed in an easy-to-use tablet format, this product provides a convenient alternative to injectable GLP-1 options
30 individually packaged sticks for convenient use
